Rank | Gene Set | Z-score |
---|---|---|
1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.26397113 |
2 | chaperone-mediated protein transport (GO:0072321) | 5.16112400 |
3 | proteasome assembly (GO:0043248) | 5.03746559 |
4 | ribosomal small subunit biogenesis (GO:0042274) | 4.81992934 |
5 | ATP synthesis coupled proton transport (GO:0015986) | 4.74944988 |
6 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.74944988 |
7 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.69815993 |
8 | ribosomal small subunit assembly (GO:0000028) | 4.61641974 |
9 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.45010923 |
10 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.41915602 |
11 | ribosomal large subunit biogenesis (GO:0042273) | 4.37546119 |
12 | regulation of mitochondrial translation (GO:0070129) | 4.19893376 |
13 | respiratory electron transport chain (GO:0022904) | 4.19046142 |
14 | maturation of SSU-rRNA (GO:0030490) | 4.17070983 |
15 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.15044358 |
16 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.13351578 |
17 | negative regulation of ligase activity (GO:0051352) | 4.10591124 |
18 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.10591124 |
19 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.10286103 |
20 | electron transport chain (GO:0022900) | 4.09829320 |
21 | viral transcription (GO:0019083) | 3.98361170 |
22 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.96199053 |
23 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.96029466 |
24 | protein targeting to mitochondrion (GO:0006626) | 3.95800705 |
25 | pseudouridine synthesis (GO:0001522) | 3.92642000 |
26 | translational termination (GO:0006415) | 3.90533743 |
27 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.85123477 |
28 | rRNA modification (GO:0000154) | 3.83561721 |
29 | protein complex biogenesis (GO:0070271) | 3.82188142 |
30 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.79077013 |
31 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.78584343 |
32 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.78584343 |
33 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.78559306 |
34 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.78559306 |
35 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.78559306 |
36 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.77829302 |
37 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.76409776 |
38 | base-excision repair, AP site formation (GO:0006285) | 3.76255042 |
39 | translation (GO:0006412) | 3.75588205 |
40 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.74560365 |
41 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.74560365 |
42 | NADH dehydrogenase complex assembly (GO:0010257) | 3.74560365 |
43 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.73156963 |
44 | termination of RNA polymerase III transcription (GO:0006386) | 3.73156963 |
45 | cotranslational protein targeting to membrane (GO:0006613) | 3.71748341 |
46 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.70237153 |
47 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.70237153 |
48 | protein targeting to ER (GO:0045047) | 3.67391587 |
49 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.66190360 |
50 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.64242391 |
51 | cellular component biogenesis (GO:0044085) | 3.63594523 |
52 | translational elongation (GO:0006414) | 3.63360365 |
53 | protein localization to mitochondrion (GO:0070585) | 3.62054020 |
54 | formation of translation preinitiation complex (GO:0001731) | 3.61067043 |
55 | establishment of protein localization to mitochondrion (GO:0072655) | 3.60686915 |
56 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.59397172 |
57 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.54811450 |
58 | oxidative phosphorylation (GO:0006119) | 3.52841371 |
59 | rRNA processing (GO:0006364) | 3.50740484 |
60 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.50599686 |
61 | ribosome assembly (GO:0042255) | 3.49566121 |
62 | protein localization to endoplasmic reticulum (GO:0070972) | 3.49245039 |
63 | chromatin remodeling at centromere (GO:0031055) | 3.47218191 |
64 | establishment of integrated proviral latency (GO:0075713) | 3.47080127 |
65 | positive regulation of ligase activity (GO:0051351) | 3.46223259 |
66 | translational initiation (GO:0006413) | 3.44048771 |
67 | CENP-A containing nucleosome assembly (GO:0034080) | 3.42290460 |
68 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.38507560 |
69 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.36284941 |
70 | transcription from mitochondrial promoter (GO:0006390) | 3.36134069 |
71 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.35946832 |
72 | cullin deneddylation (GO:0010388) | 3.35621750 |
73 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.35051194 |
74 | rRNA metabolic process (GO:0016072) | 3.33353245 |
75 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.32714583 |
76 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.32667388 |
77 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.32667388 |
78 | spliceosomal snRNP assembly (GO:0000387) | 3.32195623 |
79 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.31542575 |
80 | respiratory chain complex IV assembly (GO:0008535) | 3.30942895 |
81 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.29962480 |
82 | ribosome biogenesis (GO:0042254) | 3.29623119 |
83 | protein deneddylation (GO:0000338) | 3.28400440 |
84 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.26097793 |
85 | GTP biosynthetic process (GO:0006183) | 3.22894805 |
86 | deoxyribose phosphate catabolic process (GO:0046386) | 3.22588637 |
87 | DNA strand elongation (GO:0022616) | 3.22529824 |
88 | deoxyribonucleotide catabolic process (GO:0009264) | 3.21594901 |
89 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.20829169 |
90 | DNA damage response, detection of DNA damage (GO:0042769) | 3.19000150 |
91 | ubiquinone biosynthetic process (GO:0006744) | 3.16915606 |
92 | regulation of ligase activity (GO:0051340) | 3.16449856 |
93 | maturation of 5.8S rRNA (GO:0000460) | 3.14994358 |
94 | viral life cycle (GO:0019058) | 3.13028439 |
95 | peptidyl-histidine modification (GO:0018202) | 3.10899994 |
96 | protein-cofactor linkage (GO:0018065) | 3.10822968 |
97 | CTP biosynthetic process (GO:0006241) | 3.09325844 |
98 | CTP metabolic process (GO:0046036) | 3.09325844 |
99 | tRNA aminoacylation for protein translation (GO:0006418) | 3.05627009 |
100 | mitotic metaphase plate congression (GO:0007080) | 3.05127143 |
Rank | Gene Set | Z-score |
---|---|---|
1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.13340121 |
2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.39079108 |
3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.22956501 |
4 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.18973281 |
5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.11201251 |
6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.07670084 |
7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.77684874 |
8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.60470334 |
9 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.55499505 |
10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.55207136 |
11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.48305428 |
12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.18580704 |
13 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.98403286 |
14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.96895129 |
15 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.85186820 |
16 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.76156529 |
17 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.65114478 |
18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.64592822 |
19 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.59320859 |
20 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.58556504 |
21 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.57461716 |
22 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.46720810 |
23 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.46367744 |
24 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.42920085 |
25 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.38563258 |
26 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.38376762 |
27 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.31767184 |
28 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.26852732 |
29 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.24775976 |
30 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.24618149 |
31 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.24267094 |
32 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.16858094 |
33 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.15812490 |
34 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.14795597 |
35 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.04840517 |
36 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.97349475 |
37 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.90595000 |
38 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.82010672 |
39 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.80580205 |
40 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.78451624 |
41 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.78435242 |
42 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.72327156 |
43 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.72198950 |
44 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.67997000 |
45 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67748871 |
46 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.66496142 |
47 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.64373567 |
48 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.56009635 |
49 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.54353314 |
50 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.51984853 |
51 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.50071237 |
52 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.48767721 |
53 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.46211754 |
54 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.45532593 |
55 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.41324594 |
56 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.40168988 |
57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40105882 |
58 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.39188764 |
59 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.34612197 |
60 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.33082691 |
61 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.32683126 |
62 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28598117 |
63 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.26906793 |
64 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.22123209 |
65 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.20878487 |
66 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19342331 |
67 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.15910069 |
68 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.15084809 |
69 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.12708101 |
70 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.09088162 |
71 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.08427427 |
72 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.07142740 |
73 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.06909025 |
74 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.02955684 |
75 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.02654385 |
76 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99617447 |
77 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.99503337 |
78 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.98072876 |
79 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94993396 |
80 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.94863371 |
81 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.94184010 |
82 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.92643204 |
83 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.91705285 |
84 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.88793820 |
85 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.87930776 |
86 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.87360304 |
87 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.86917619 |
88 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.86790111 |
89 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.85526672 |
90 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.84460201 |
91 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.82252543 |
92 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.79729965 |
93 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.79306488 |
94 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79243598 |
95 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.77398778 |
96 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.76942433 |
97 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.76186999 |
98 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.76030430 |
99 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.75286484 |
100 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.70864950 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008058_abnormal_DNA_repair | 4.80839237 |
2 | MP0003693_abnormal_embryo_hatching | 4.75252669 |
3 | MP0004957_abnormal_blastocyst_morpholog | 3.93535393 |
4 | MP0010094_abnormal_chromosome_stability | 3.86587471 |
5 | MP0003806_abnormal_nucleotide_metabolis | 3.71352510 |
6 | MP0003111_abnormal_nucleus_morphology | 3.35551015 |
7 | MP0003077_abnormal_cell_cycle | 3.12140077 |
8 | MP0008932_abnormal_embryonic_tissue | 3.06027054 |
9 | MP0006036_abnormal_mitochondrial_physio | 2.95800867 |
10 | MP0003186_abnormal_redox_activity | 2.86614709 |
11 | MP0003786_premature_aging | 2.70437415 |
12 | MP0006292_abnormal_olfactory_placode | 2.60131776 |
13 | MP0006035_abnormal_mitochondrial_morpho | 2.46426048 |
14 | MP0009379_abnormal_foot_pigmentation | 2.35194003 |
15 | MP0003718_maternal_effect | 2.29610100 |
16 | MP0008007_abnormal_cellular_replicative | 2.27364854 |
17 | MP0000372_irregular_coat_pigmentation | 2.15814114 |
18 | MP0009697_abnormal_copulation | 2.13966468 |
19 | MP0008789_abnormal_olfactory_epithelium | 1.80755908 |
20 | MP0010030_abnormal_orbit_morphology | 1.77414902 |
21 | MP0003646_muscle_fatigue | 1.61909183 |
22 | MP0001730_embryonic_growth_arrest | 1.61713515 |
23 | MP0002160_abnormal_reproductive_system | 1.58542776 |
24 | MP0000749_muscle_degeneration | 1.58168016 |
25 | MP0000358_abnormal_cell_content/ | 1.57773717 |
26 | MP0001293_anophthalmia | 1.54387205 |
27 | MP0001529_abnormal_vocalization | 1.47615127 |
28 | MP0005084_abnormal_gallbladder_morpholo | 1.46972276 |
29 | MP0001764_abnormal_homeostasis | 1.40983855 |
30 | MP0000350_abnormal_cell_proliferation | 1.40940894 |
31 | MP0008057_abnormal_DNA_replication | 1.40145464 |
32 | MP0002938_white_spotting | 1.39226737 |
33 | MP0004147_increased_porphyrin_level | 1.38931725 |
34 | MP0003315_abnormal_perineum_morphology | 1.36432393 |
35 | MP0005408_hypopigmentation | 1.33518761 |
36 | MP0002837_dystrophic_cardiac_calcinosis | 1.27005892 |
37 | MP0000313_abnormal_cell_death | 1.26644902 |
38 | MP0008995_early_reproductive_senescence | 1.26323944 |
39 | MP0001697_abnormal_embryo_size | 1.25999026 |
40 | MP0001727_abnormal_embryo_implantation | 1.24771644 |
41 | MP0008875_abnormal_xenobiotic_pharmacok | 1.24761744 |
42 | MP0002102_abnormal_ear_morphology | 1.24503745 |
43 | MP0002210_abnormal_sex_determination | 1.23105030 |
44 | MP0000750_abnormal_muscle_regeneration | 1.20667023 |
45 | MP0004145_abnormal_muscle_electrophysio | 1.19566067 |
46 | MP0004233_abnormal_muscle_weight | 1.17520446 |
47 | MP0005330_cardiomyopathy | 1.09809628 |
48 | MP0005394_taste/olfaction_phenotype | 1.08356137 |
49 | MP0005499_abnormal_olfactory_system | 1.08356137 |
50 | MP0002080_prenatal_lethality | 1.06916594 |
51 | MP0005389_reproductive_system_phenotype | 1.05935087 |
52 | MP0001929_abnormal_gametogenesis | 1.05510413 |
53 | MP0003567_abnormal_fetal_cardiomyocyte | 1.02357528 |
54 | MP0003221_abnormal_cardiomyocyte_apopto | 1.00276324 |
55 | MP0005670_abnormal_white_adipose | 0.99929714 |
56 | MP0001672_abnormal_embryogenesis/_devel | 0.99226713 |
57 | MP0005380_embryogenesis_phenotype | 0.99226713 |
58 | MP0001145_abnormal_male_reproductive | 0.97536166 |
59 | MP0005501_abnormal_skin_physiology | 0.95789288 |
60 | MP0005332_abnormal_amino_acid | 0.95046479 |
61 | MP0002163_abnormal_gland_morphology | 0.94987733 |
62 | MP0000653_abnormal_sex_gland | 0.93205636 |
63 | MP0001881_abnormal_mammary_gland | 0.93121841 |
64 | MP0005075_abnormal_melanosome_morpholog | 0.92025869 |
65 | MP0003011_delayed_dark_adaptation | 0.88434566 |
66 | MP0003941_abnormal_skin_development | 0.87599228 |
67 | MP0002269_muscular_atrophy | 0.86365054 |
68 | MP0003123_paternal_imprinting | 0.86104688 |
69 | MP0001905_abnormal_dopamine_level | 0.84367913 |
70 | MP0001919_abnormal_reproductive_system | 0.84355733 |
71 | MP0002085_abnormal_embryonic_tissue | 0.83945516 |
72 | MP0008877_abnormal_DNA_methylation | 0.83858780 |
73 | MP0001661_extended_life_span | 0.83573442 |
74 | MP0002234_abnormal_pharynx_morphology | 0.83159207 |
75 | MP0000049_abnormal_middle_ear | 0.82687151 |
76 | MP0002019_abnormal_tumor_incidence | 0.82199056 |
77 | MP0003984_embryonic_growth_retardation | 0.78233596 |
78 | MP0002088_abnormal_embryonic_growth/wei | 0.76235276 |
79 | MP0005083_abnormal_biliary_tract | 0.76016331 |
80 | MP0004142_abnormal_muscle_tone | 0.73443331 |
81 | MP0002084_abnormal_developmental_patter | 0.72971051 |
82 | MP0001119_abnormal_female_reproductive | 0.72599138 |
83 | MP0003937_abnormal_limbs/digits/tail_de | 0.71035992 |
84 | MP0005379_endocrine/exocrine_gland_phen | 0.70615255 |
85 | MP0005266_abnormal_metabolism | 0.69362029 |
86 | MP0002090_abnormal_vision | 0.68357108 |
87 | MP0002233_abnormal_nose_morphology | 0.66447246 |
88 | MP0009333_abnormal_splenocyte_physiolog | 0.65766270 |
89 | MP0004197_abnormal_fetal_growth/weight/ | 0.64654140 |
90 | MP0000747_muscle_weakness | 0.63657444 |
91 | MP0001346_abnormal_lacrimal_gland | 0.63541753 |
92 | MP0000751_myopathy | 0.61071258 |
93 | MP0001188_hyperpigmentation | 0.60719385 |
94 | MP0003698_abnormal_male_reproductive | 0.59379860 |
95 | MP0003936_abnormal_reproductive_system | 0.58832053 |
96 | MP0002111_abnormal_tail_morphology | 0.58692778 |
97 | MP0005636_abnormal_mineral_homeostasis | 0.57451794 |
98 | MP0005645_abnormal_hypothalamus_physiol | 0.56187287 |
99 | MP0001286_abnormal_eye_development | 0.55447311 |
100 | MP0009672_abnormal_birth_weight | 0.54268724 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Acute necrotizing encephalopathy (HP:0006965) | 5.77734844 |
2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.51643767 |
3 | Acute encephalopathy (HP:0006846) | 5.36621187 |
4 | Mitochondrial inheritance (HP:0001427) | 4.99248648 |
5 | Increased CSF lactate (HP:0002490) | 4.88343789 |
6 | Progressive macrocephaly (HP:0004481) | 4.58068502 |
7 | Hepatocellular necrosis (HP:0001404) | 4.57584986 |
8 | Increased hepatocellular lipid droplets (HP:0006565) | 4.17132217 |
9 | Hepatic necrosis (HP:0002605) | 4.16638232 |
10 | Cerebral edema (HP:0002181) | 3.98736937 |
11 | Lipid accumulation in hepatocytes (HP:0006561) | 3.96957684 |
12 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.96043766 |
13 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.96043766 |
14 | Increased serum pyruvate (HP:0003542) | 3.90252169 |
15 | Increased serum lactate (HP:0002151) | 3.89860328 |
16 | Lactic acidosis (HP:0003128) | 3.74463680 |
17 | Increased intramyocellular lipid droplets (HP:0012240) | 3.59302947 |
18 | Abnormality of glycolysis (HP:0004366) | 3.57956562 |
19 | Exercise intolerance (HP:0003546) | 3.40894129 |
20 | Microvesicular hepatic steatosis (HP:0001414) | 3.33249052 |
21 | Renal Fanconi syndrome (HP:0001994) | 3.30902228 |
22 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.30253549 |
23 | Respiratory failure (HP:0002878) | 3.20160969 |
24 | 3-Methylglutaconic aciduria (HP:0003535) | 3.11530785 |
25 | Reticulocytopenia (HP:0001896) | 3.11012962 |
26 | Increased muscle lipid content (HP:0009058) | 3.09319222 |
27 | Progressive muscle weakness (HP:0003323) | 3.08838933 |
28 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.96303961 |
29 | Abnormality of alanine metabolism (HP:0010916) | 2.89920310 |
30 | Hyperalaninemia (HP:0003348) | 2.89920310 |
31 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.89920310 |
32 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.89342585 |
33 | Type I transferrin isoform profile (HP:0003642) | 2.88064075 |
34 | Abnormal number of erythroid precursors (HP:0012131) | 2.87581804 |
35 | Macrocytic anemia (HP:0001972) | 2.79711969 |
36 | Reduced antithrombin III activity (HP:0001976) | 2.76098530 |
37 | Ragged-red muscle fibers (HP:0003200) | 2.68774100 |
38 | Leukodystrophy (HP:0002415) | 2.67749077 |
39 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.66802109 |
40 | Methylmalonic aciduria (HP:0012120) | 2.60264194 |
41 | Lethargy (HP:0001254) | 2.55631644 |
42 | Pancytopenia (HP:0001876) | 2.54297069 |
43 | Optic disc pallor (HP:0000543) | 2.52946594 |
44 | Abnormal protein glycosylation (HP:0012346) | 2.50792991 |
45 | Abnormal glycosylation (HP:0012345) | 2.50792991 |
46 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.50792991 |
47 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.50792991 |
48 | Respiratory difficulties (HP:0002880) | 2.50005906 |
49 | Exertional dyspnea (HP:0002875) | 2.48100383 |
50 | Abnormality of the anterior horn cell (HP:0006802) | 2.46638706 |
51 | Degeneration of anterior horn cells (HP:0002398) | 2.46638706 |
52 | Aplastic anemia (HP:0001915) | 2.43042633 |
53 | Multiple enchondromatosis (HP:0005701) | 2.42073119 |
54 | CNS demyelination (HP:0007305) | 2.35923985 |
55 | Microretrognathia (HP:0000308) | 2.29550973 |
56 | Hyperglycinemia (HP:0002154) | 2.24455775 |
57 | Colon cancer (HP:0003003) | 2.23206209 |
58 | Cerebral hypomyelination (HP:0006808) | 2.17231666 |
59 | Emotional lability (HP:0000712) | 2.13204197 |
60 | Abnormality of serum amino acid levels (HP:0003112) | 2.03928163 |
61 | Dicarboxylic aciduria (HP:0003215) | 2.02818115 |
62 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.02818115 |
63 | Cleft eyelid (HP:0000625) | 2.02039557 |
64 | Abnormality of placental membranes (HP:0011409) | 1.96515832 |
65 | Amniotic constriction ring (HP:0009775) | 1.96515832 |
66 | X-linked dominant inheritance (HP:0001423) | 1.95749904 |
67 | Horseshoe kidney (HP:0000085) | 1.95158749 |
68 | Rough bone trabeculation (HP:0100670) | 1.92089662 |
69 | Chromsome breakage (HP:0040012) | 1.91039078 |
70 | Oral leukoplakia (HP:0002745) | 1.90252240 |
71 | Abnormality of the preputium (HP:0100587) | 1.90245142 |
72 | Testicular atrophy (HP:0000029) | 1.90169039 |
73 | Sparse eyelashes (HP:0000653) | 1.89855343 |
74 | Meckel diverticulum (HP:0002245) | 1.89822455 |
75 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.89286602 |
76 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.89173764 |
77 | Pallor (HP:0000980) | 1.84507030 |
78 | Muscle fiber atrophy (HP:0100295) | 1.81520228 |
79 | Hyperglycinuria (HP:0003108) | 1.80108205 |
80 | Birth length less than 3rd percentile (HP:0003561) | 1.79952726 |
81 | Abnormality of the ileum (HP:0001549) | 1.78694849 |
82 | Type 2 muscle fiber atrophy (HP:0003554) | 1.78338029 |
83 | Absent thumb (HP:0009777) | 1.77559860 |
84 | Premature ovarian failure (HP:0008209) | 1.77093308 |
85 | Abnormality of renal resorption (HP:0011038) | 1.75971265 |
86 | Abnormality of glycine metabolism (HP:0010895) | 1.75368538 |
87 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.75368538 |
88 | Glycosuria (HP:0003076) | 1.73224705 |
89 | Abnormality of urine glucose concentration (HP:0011016) | 1.73224705 |
90 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.70905251 |
91 | Generalized aminoaciduria (HP:0002909) | 1.68533273 |
92 | Hyperphosphaturia (HP:0003109) | 1.67801827 |
93 | Abnormality of methionine metabolism (HP:0010901) | 1.67799868 |
94 | Facial cleft (HP:0002006) | 1.67111692 |
95 | CNS hypomyelination (HP:0003429) | 1.66224880 |
96 | Progressive microcephaly (HP:0000253) | 1.64899485 |
97 | Methylmalonic acidemia (HP:0002912) | 1.63344678 |
98 | Postnatal microcephaly (HP:0005484) | 1.63070800 |
99 | Progressive external ophthalmoplegia (HP:0000590) | 1.62764547 |
100 | Blindness (HP:0000618) | 1.61971970 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK16 | 4.35902772 |
2 | BUB1 | 4.23425191 |
3 | VRK2 | 4.18376254 |
4 | NME2 | 4.07665402 |
5 | CDC7 | 2.80154309 |
6 | NEK1 | 2.79170369 |
7 | EIF2AK1 | 2.65668279 |
8 | MST4 | 2.51026476 |
9 | SRPK1 | 2.38042968 |
10 | ZAK | 2.34156963 |
11 | BCKDK | 2.33404138 |
12 | PDK2 | 2.17720354 |
13 | PBK | 2.09783252 |
14 | VRK1 | 2.07313235 |
15 | EIF2AK3 | 1.98043984 |
16 | NME1 | 1.97652681 |
17 | TTK | 1.90833199 |
18 | SCYL2 | 1.74587833 |
19 | PLK4 | 1.70690812 |
20 | TSSK6 | 1.69432215 |
21 | TESK2 | 1.58152823 |
22 | TRIM28 | 1.55660963 |
23 | NUAK1 | 1.51004274 |
24 | PLK3 | 1.48312061 |
25 | PLK1 | 1.43208728 |
26 | DYRK3 | 1.41610615 |
27 | LIMK1 | 1.36499413 |
28 | AURKB | 1.30859479 |
29 | WEE1 | 1.30721643 |
30 | CCNB1 | 1.26811286 |
31 | ABL2 | 1.26250637 |
32 | AURKA | 1.22221188 |
33 | MAPKAPK3 | 1.19964428 |
34 | CDK8 | 1.17996891 |
35 | MAP3K12 | 1.15089344 |
36 | KDR | 1.14672872 |
37 | TLK1 | 1.14169399 |
38 | PIM2 | 1.13651322 |
39 | BRSK1 | 1.13000743 |
40 | CSNK1G3 | 1.12934429 |
41 | DYRK2 | 1.08773449 |
42 | ARAF | 1.08344701 |
43 | TAF1 | 1.02129464 |
44 | ATR | 1.01279139 |
45 | RPS6KB2 | 1.00296055 |
46 | DAPK1 | 0.98094387 |
47 | TESK1 | 0.94627038 |
48 | CHEK2 | 0.94063533 |
49 | MAP4K2 | 0.92583501 |
50 | CSNK1A1L | 0.92443843 |
51 | MAPKAPK5 | 0.88688281 |
52 | MST1R | 0.88183102 |
53 | CSNK1G1 | 0.87784780 |
54 | EIF2AK2 | 0.85068545 |
55 | BRSK2 | 0.83713859 |
56 | CSNK1G2 | 0.81221607 |
57 | RPS6KA5 | 0.80824453 |
58 | CDK19 | 0.79064331 |
59 | CSNK2A2 | 0.77679481 |
60 | STK4 | 0.76798383 |
61 | CDK7 | 0.75562775 |
62 | BRAF | 0.74116705 |
63 | RPS6KA4 | 0.73513204 |
64 | PAK4 | 0.71374673 |
65 | CSNK2A1 | 0.71295630 |
66 | CHEK1 | 0.69781514 |
67 | NEK2 | 0.69365787 |
68 | MAP2K7 | 0.69225984 |
69 | PRKCI | 0.67064187 |
70 | MUSK | 0.66119740 |
71 | ILK | 0.62677822 |
72 | DAPK3 | 0.61650044 |
73 | MAP3K8 | 0.61050756 |
74 | BCR | 0.61031175 |
75 | OBSCN | 0.60118344 |
76 | MKNK1 | 0.59457465 |
77 | AKT2 | 0.58827529 |
78 | LRRK2 | 0.58291871 |
79 | EPHA2 | 0.56907751 |
80 | PAK1 | 0.51298710 |
81 | MAP3K4 | 0.45431335 |
82 | ATM | 0.43550661 |
83 | IRAK3 | 0.43293504 |
84 | BMPR1B | 0.42541615 |
85 | STK10 | 0.39421806 |
86 | CSNK1E | 0.35874331 |
87 | SMG1 | 0.33855799 |
88 | PHKG1 | 0.33059791 |
89 | PHKG2 | 0.33059791 |
90 | CDK1 | 0.31756596 |
91 | CDK2 | 0.30701496 |
92 | TAOK2 | 0.30640624 |
93 | CDK14 | 0.29582109 |
94 | ERBB4 | 0.28658616 |
95 | MINK1 | 0.28602395 |
96 | PINK1 | 0.28445171 |
97 | GRK1 | 0.28444598 |
98 | CSNK1A1 | 0.26768764 |
99 | WNK3 | 0.25439384 |
100 | MKNK2 | 0.25049872 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 4.61321680 |
2 | Ribosome_Homo sapiens_hsa03010 | 4.02980098 |
3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.45258673 |
4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.12359101 |
5 | DNA replication_Homo sapiens_hsa03030 | 3.08177487 |
6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.86805899 |
7 | RNA polymerase_Homo sapiens_hsa03020 | 2.76374430 |
8 | Mismatch repair_Homo sapiens_hsa03430 | 2.73872813 |
9 | Base excision repair_Homo sapiens_hsa03410 | 2.37981822 |
10 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.31225949 |
11 | Huntingtons disease_Homo sapiens_hsa05016 | 2.26765134 |
12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.17582323 |
13 | Protein export_Homo sapiens_hsa03060 | 2.13286153 |
14 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.12772516 |
15 | Homologous recombination_Homo sapiens_hsa03440 | 2.11955934 |
16 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.06737097 |
17 | Spliceosome_Homo sapiens_hsa03040 | 2.02599785 |
18 | Alzheimers disease_Homo sapiens_hsa05010 | 1.95057225 |
19 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.87613577 |
20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.87029832 |
21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.84451305 |
22 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.77451573 |
23 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.76962689 |
24 | RNA transport_Homo sapiens_hsa03013 | 1.71916686 |
25 | Sulfur relay system_Homo sapiens_hsa04122 | 1.61715794 |
26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.60847930 |
27 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.53728468 |
28 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.53699504 |
29 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.52782415 |
30 | RNA degradation_Homo sapiens_hsa03018 | 1.47098556 |
31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41667716 |
32 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.34828434 |
33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.34796664 |
34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.33883498 |
35 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.32613263 |
36 | Basal transcription factors_Homo sapiens_hsa03022 | 1.31776552 |
37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.29752147 |
38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.28321062 |
39 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.26050527 |
40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24189029 |
41 | Purine metabolism_Homo sapiens_hsa00230 | 1.23001954 |
42 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.11620832 |
43 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.04326547 |
44 | Cell cycle_Homo sapiens_hsa04110 | 1.04271991 |
45 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.94068678 |
46 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89087000 |
47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.88133107 |
48 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.87800392 |
49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.86964126 |
50 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.86004728 |
51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85020035 |
52 | Metabolic pathways_Homo sapiens_hsa01100 | 0.83537137 |
53 | Peroxisome_Homo sapiens_hsa04146 | 0.76352718 |
54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75408344 |
55 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75164752 |
56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73383550 |
57 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.70342401 |
58 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.64509462 |
59 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.64116103 |
60 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63306197 |
61 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62848038 |
62 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.62675827 |
63 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60872271 |
64 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.56435962 |
65 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.54523098 |
66 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.54164065 |
67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53494480 |
68 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.52730878 |
69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47664255 |
70 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.47647782 |
71 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.46925222 |
72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45153258 |
73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42628927 |
74 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.42336181 |
75 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.37091390 |
76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34687524 |
77 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.34512257 |
78 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.34260704 |
79 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.33219990 |
80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.31527861 |
81 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.29680616 |
82 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.29177046 |
83 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.27962027 |
84 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.27706327 |
85 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.27619127 |
86 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.26363324 |
87 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.23747618 |
88 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.21472305 |
89 | Alcoholism_Homo sapiens_hsa05034 | 0.20126244 |
90 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.18085405 |
91 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.16417809 |
92 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.15249033 |
93 | Retinol metabolism_Homo sapiens_hsa00830 | 0.13984045 |
94 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.12659395 |
95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.08509774 |
96 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.06954000 |
97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.05530859 |
98 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.05256811 |
99 | Asthma_Homo sapiens_hsa05310 | 0.02822209 |
100 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.02448294 |